CStone Pharmaceuticals
CSPHF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$270,183 | -$106,906 | $15,699 | -$158,008 |
| Dep. & Amort. | $0 | $25,798 | $24,007 | $28,929 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | -$1,525 | -$7,462 | $4,651 | $10,805 |
| Change in WC | $0 | -$48,201 | -$117,696 | -$61,890 |
| Other Non-Cash | $271,708 | -$19,278 | -$113,793 | -$67,852 |
| Operating Cash Flow | $0 | -$156,049 | -$187,132 | -$248,016 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | -$15 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | -$149,950 | -$97,729 | $221,684 |
| Investing Cash Flow | $0 | -$149,950 | -$97,729 | $221,669 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $22,577 | -$35,473 | $122,681 |
| Financing Cash Flow | $0 | $22,577 | -$35,473 | $122,681 |
| Forex Effect | $0 | -$7,497 | $2,519 | -$5,887 |
| Net Chg. in Cash | $0 | $0 | -$158,908 | $45,224 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $0 | $0 | -$158,908 | $45,224 |
| End Cash | $0 | $0 | -$158,908 | $45,224 |
| Free Cash Flow | $0 | -$156,049 | -$187,132 | -$248,031 |